Ozenoxacin Raw Material Ozenoxacin Powder

CAS: 245765-41-7

MF: C21H21N3O3

MW:363.41

EINECS: 105-745-2

Specification​: 99% min Ozenoxacin 

Sample: Ozenoxacin Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

China Ozenoxacin Raw Material Ozenoxacin Powder Factory Supply Ozenoxacin Raw Material, High Quality Ozenoxacin Powder Purity 99% Ozenoxacin Raw Powder CAS 245765-41-7. Ozenoxacin Powder is a quinolone drug used to treat impetigo.

Uses and functions of Ozenoxacin Powder

Ozefloxacin is a quinolone antimicrobial drug developed by FerrerInternacional Ltd. in Spain, purchased by Medimetriks Pharmaceuticals Inc. in the U.S. with exclusive U.S. commercialisation rights, and approved by the Ministry of Health, Labour and Welfare of Japan in September 2015 as the first new molecular entity to be approved globally, and approved for marketing by the FDA in the U.S. on 11 December 2017.

Pharmacological Effects of Ozenoxacin Raw Powder

The mechanism of action of of ofloxacin is inhibition of bacterial DNA replicase, DNA procyclase A and topoisomerase IV. ofloxacin is the third non-fluoroquinolone antimicrobial drug approved globally after nenoxacin and galefloxacin. Clinical trials have used ofloxacin in the treatment of skin and soft tissue infections with superior efficacy to mupirocin and no significant adverse effects.

The inhibitory effect of Ozenfloxacin on MRSA, methicillin-sensitive Staphylococcus aureus (MSSA), and ofloxacin-resistant Staphylococcus aureus is significantly stronger than that of nafloxacin, ofloxacin, levofloxacin, clindamycin, erythromycin and gentamicin. Ozemifloxacin has strong bactericidal activity and can become a new quinolone drug with shortened treatment course and good clinical application prospect.

Production method of Raw Ozenoxacin Powder